ESSA Pharma Inc. Share Price Toronto S.E.
Equities
EPI
CA29668H7085
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 371M 271M 21.61B |
---|---|---|---|---|---|
Net income 2024 * | -48M -35.03M -2.8B | Net income 2025 * | -78M -56.93M -4.55B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.72
x | P/E ratio 2025 * |
-5.49
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.72% |
Latest transcript on ESSA Pharma Inc.
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 23/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 30/09/13 |
Peter Virsik
COO | Chief Operating Officer | - | 31/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 04/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 30/07/19 |
Richard Glickman
CHM | Chairman | 65 | 30/09/10 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |